Effect of Donated Plasma on Laboratory Parameters and Motivating Factors of Donated Plasma
Author(s)
Czifra I1, Vajda R2, Kajos L3, Kovács B4, Boncz I4, Kívés Z5
1University of Pécs, Institute for Health Insurance, Pécs, Hungary, Hungary, 2University of Pécs, Pécs, Hungary, 3University of Pécs, Pécs, BA, Hungary, 4University of Pécs, BUDAPEST, PE, Hungary, 5University of Pécs, PÉCS, BA, Hungary
Presentation Documents
OBJECTIVES: Medical therapeutic blood products, such as plasma-derived drugs, play a crucial role in health care. This research aims to reveal the motive for donating plasma among donors and to examine the changes in laboratory results during the donation.
METHODS: The retrospective research was conducted in a plasma centre in Hungary between 01.01.2019. and 30.12.2022(n=100). Scope of collected data: gender, haemoglobin (HGB), thrombocyte (PLT) hematocrit (HTC), red blood cell (RBC), white blood cell (WBC), total protein level, after the first (1st), fifth (5th) and fifteenth (15th) plasma donation. The cross-sectional survey was conducted among donors aged 18-65 (n=200). The questionnaire covered sociodemographic data, information sources, number of weekly plasma donations and motivation. Descriptive statistical analysis and repeated ANOVA (p<0.05) were performed using SPSS 28.0 software.
RESULTS: The RBC count (1st: 4.94 T/L; 5th: 4.77 T/L; 15th: 4.68 T/L), the WBC count (1st: 6.79 G/L; 5th: 6.61 G/L; 15th: 6.54 G/L and PLT count (1st: 199.57 G/L; 5th: 192.56 G/L; 15th: 186.15 G/L) decreased significantly (p<0.001), but remained within the normal range. The level of HMG of women (1: 130 G/L; 15: 127 G/L) (p<0.001) and men (1: 145.6 G/L; 15: 137.1 G/L) significantly decreased (p<0.001). Total plasma protein (1st: 7.7 G/L; 5th: 7.1 G/L; 15th: 6.7 G/L) also decreased (p<0.001) but remained in the normal range. The primary sources of information comprise a friend (41.5%) and the Internet (36%). The main motive is helping others (70%) and benefits (54%). The main motive for later plasma donation is more benefits (67.5%). 45.5% of respondents plan to donate plasma 3-4 times a month, 42% at most.
CONCLUSIONS: All donor parameters tested decreased during donation but remained within the normal range. The benefits are still a source of motivation.
Conference/Value in Health Info
Value in Health, Volume 27, Issue 6, S1 (June 2024)
Code
CO51
Topic
Clinical Outcomes, Epidemiology & Public Health, Medical Technologies, Study Approaches
Topic Subcategory
Clinical Outcomes Assessment, Clinical Trials, Diagnostics & Imaging, Public Health
Disease
Biologics & Biosimilars, Systemic Disorders/Conditions (Anesthesia, Auto-Immune Disorders (n.e.c.), Hematological Disorders (non-oncologic), Pain)